Page last updated: 2024-10-21

5-hydroxydecanoate and Hematoma, Subdural, Acute

5-hydroxydecanoate has been researched along with Hematoma, Subdural, Acute in 1 studies

5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd

Hematoma, Subdural, Acute: Accumulation of blood in the SUBDURAL SPACE with acute onset of neurological symptoms. Symptoms may include loss of consciousness, severe HEADACHE, and deteriorating mental status.

Research Excerpts

ExcerptRelevanceReference
"Pretreatment with diazoxide significantly reduced infarct volume and brain edema formation after ASDH."1.39The neuroprotective effect of diazoxide is mediated by mitochondrial ATP-dependent potassium channels in a rat model of acute subdural hematoma. ( Nakagawa, I; Nakase, H; Nishimura, F; Park, YS; Tamura, K; Wajima, D, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakagawa, I1
Wajima, D1
Tamura, K1
Nishimura, F1
Park, YS1
Nakase, H1

Other Studies

1 other study available for 5-hydroxydecanoate and Hematoma, Subdural, Acute

ArticleYear
The neuroprotective effect of diazoxide is mediated by mitochondrial ATP-dependent potassium channels in a rat model of acute subdural hematoma.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2013, Volume: 20, Issue:1

    Topics: Animals; Brain Infarction; Decanoic Acids; Diazoxide; Disease Models, Animal; Hematoma, Subdural, Ac

2013